Showing results 15 to 34 of 43
< previous
next >
| Issue Date | Title | Author(s) |
| 2019-07-01 | IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis | Starkey, MR; Plank, MW; Casolari, P; Papi, A; Pavlidis, S; Guo, Y; Cameron, GJM; Haw, TJ; Tam, A; Obiedat, M; Donovan, C; Hansbro, NG; Nguyen, DH; Nair, PM; Kim, RY; Horvat, JC; Kaiko, GE; Durum, SK; Wark, PA; Sin, DD; Caramori, G; Adcock, IM; Foster, PS; Hansbro, PM |
| 2019-04-01 | Lung development and emerging roles for type 2 immunity | Loering, S; Cameron, GJM; Starkey, MR; Hansbro, PM |
| 2019 | Lung development and emerging roles for type 2 immunity | HANSBRO, PM; Loering, S; Cameron, GJM; Starkey, MR |
| 2015-05 | Macrolide therapy suppresses key features of experimental steroid-sensitive and steroid-insensitive asthma. | Essilfie, A-T; Horvat, JC; Kim, RY; Mayall, JR; Pinkerton, JW; Beckett, EL; Starkey, MR; Simpson, JL; Foster, PS; Gibson, PG; Hansbro, PM |
| 2017-07-01 | Mechanisms and treatments for severe, steroid-resistant allergic airway disease and asthma | Hansbro, PM; Kim, RY; Starkey, MR; Donovan, C; Dua, K; Mayall, JR; Liu, G; Hansbro, NG; Simpson, JL; Wood, LG; Hirota, JA; Knight, DA; Foster, PS; Horvat, JC |
| 2017-04-06 | MicroRNA-125a and -b inhibit A20 and MAVS to promote inflammation and impair antiviral response in COPD | Hsu, ACY; Dua, K; Starkey, MR; Haw, TJ; Nair, PM; Nichol, K; Zammit, N; Grey, ST; Baines, KJ; Foster, PS; Hansbro, PM; Wark, PA |
| 2017-02-01 | MicroRNA-21 drives severe, steroid-insensitive experimental asthma by amplifying phosphoinositide 3-kinase–mediated suppression of histone deacetylase 2 | Kim, RY; Horvat, JC; Pinkerton, JW; Starkey, MR; Essilfie, AT; Mayall, JR; Nair, PM; Hansbro, NG; Jones, B; Haw, TJ; Sunkara, KP; Nguyen, TH; Jarnicki, AG; Keely, S; Mattes, J; Adcock, IM; Foster, PS; Hansbro, PM |
| 2016-01-11 | The MIF antagonist ISO-1 attenuates corticosteroid-insensitive inflammation and airways hyperresponsiveness in an ozone-induced model of COPD | Russell, KE; Chung, KF; Clarke, CJ; Durham, AL; Mallia, P; Footitt, J; Johnston, SL; Barnes, PJ; Hall, SR; Simpson, KD; Starkey, MR; Hansbro, PM; Adcock, IM; Wiegman, CH |
| 2016-05-01 | Mucosal production of uric acid by airway epithelial cells contributes to particulate matter-induced allergic sensitization | Gold, MJ; Hiebert, PR; Park, HY; Stefanowicz, D; Le, A; Starkey, MR; Deane, A; Brown, AC; Liu, G; Horvat, JC; Ibrahim, ZA; Sukkar, MB; Hansbro, PM; Carlsten, C; Vaneeden, S; Sin, DD; McNagny, KM; Knight, DA; Hirota, JA |
| 2018-06-01 | Obese asthmatics are characterized by altered adipose tissue macrophage activation | Periyalil, HA; Wood, LG; Wright, TA; Karihaloo, C; Starkey, MR; Miu, AS; Baines, KJ; Hansbro, PM; Gibson, PG |
| 2016-04 | Programmed Death Ligand 1 Promotes Early-Life Chlamydia Respiratory Infection-Induced Severe Allergic Airway Disease. | Starkey, MR; Nguyen, DH; Brown, AC; Essilfie, A-T; Kim, RY; Yagita, H; Horvat, JC; Hansbro, PM |
| 2019-03-01 | Pulmonary group 2 innate lymphoid cells: surprises and challenges | Starkey, MR; McKenzie, AN; Belz, GT; Hansbro, PM |
| 2021-10-19 | Relationship between type 2 cytokine and inflammasome responses in obesity-associated asthma. | Pinkerton, JW; Kim, RY; Brown, AC; Rae, BE; Donovan, C; Mayall, JR; Carroll, OR; Khadem Ali, M; Scott, HA; Berthon, BS; Baines, KJ; Starkey, MR; Kermani, NZ; Guo, Y-K; Robertson, AAB; O'Neill, LAJ; Adcock, IM; Cooper, MA; Gibson, PG; Wood, LG; Hansbro, PM; Horvat, JC |
| 2018-03-01 | RelB-deficient dendritic cells promote the development of spontaneous allergic airway inflammation | Nair, PM; Starkey, MR; Haw, TJ; Ruscher, R; Liu, G; Maradana, MR; Thomas, R; O'Sullivan, BJ; Hansbro, PM |
| 2017-08-01 | Role for NLRP3 inflammasome-mediated, IL-1β-dependent responses in severe, steroid-resistant asthma | Kim, RY; Pinkerton, JW; Essilfie, AT; Robertson, AAB; Baines, KJ; Brown, AC; Mayall, JR; Ali, MK; Starkey, MR; Hansbro, NG; Hirota, JA; Wood, LG; Simpson, JL; Knight, DA; Wark, PA; Gibson, PG; O'Neill, LAJ; Cooper, MA; Horvat, JC; Hansbro, PM |
| 2017-07-01 | Role of iron in the pathogenesis of respiratory disease | Ali, MK; Kim, RY; Karim, R; Mayall, JR; Martin, KL; Shahandeh, A; Abbasian, F; Starkey, MR; Loustaud-Ratti, V; Johnstone, D; Milward, EA; Hansbro, PM; Horvat, JC |
| 2019-01-01 | Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease | Donovan, C; Starkey, MR; Kim, RY; Rana, BMJ; Barlow, JL; Jones, B; Haw, TJ; Mono Nair, P; Budden, K; Cameron, GJM; Horvat, JC; Wark, PA; Foster, PS; McKenzie, ANJ; Hansbro, PM |
| 2017-02-14 | Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling | Kedzierski, L; Tate, MD; Hsu, AC; Kolesnik, TB; Linossi, EM; Dagley, L; Dong, Z; Freeman, S; Infusini, G; Starkey, MR; Bird, NL; Chatfield, SM; Babon, JJ; Huntington, N; Belz, G; Webb, A; Wark, PA; Nicola, NA; Xu, J; Kedzierska, K; Hansbro, PM; Nicholson, SE |
| 2015-05 | Targeting PI3K-p110α Suppresses Influenza Virus Infection in Chronic Obstructive Pulmonary Disease. | Hsu, AC-Y; Starkey, MR; Hanish, I; Parsons, K; Haw, TJ; Howland, LJ; Barr, I; Mahony, JB; Foster, PS; Knight, DA; Wark, PA; Hansbro, PM |
| 2017-12-01 | Targeting PP2A and proteasome activity ameliorates features of allergic airway disease in mice | Nair, PM; Starkey, MR; Haw, TJ; Liu, G; Horvat, JC; Morris, JC; Verrills, NM; Clark, AR; Ammit, AJ; Hansbro, PM |
